CMS
57
2
MAC
53
5
EMR
57
7
D
32
10
TGNA
48
5
AAL
56
5
GME
61
2
JPM
59
6
PHM
44
4
GILD
55
5
HIG
48
5
HBAN
47
7
MMM
35
3
NWL
48
4
MO
47
6
BXP
39
5
EQT
47
13
EXR
42
5
BDX
59
3
MTB
38
4
CMS
57
2
MAC
53
5
EMR
57
7
D
32
10
TGNA
48
5
AAL
56
5
GME
61
2
JPM
59
6
PHM
44
4
GILD
55
5
HIG
48
5
HBAN
47
7
MMM
35
3
NWL
48
4
MO
47
6
BXP
39
5
EQT
47
13
EXR
42
5
BDX
59
3
MTB
38
4
Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Sell
45

MEDP
Medpace Holdings

Last Price:
$337.01
Seasonality Move:
-3.01%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

Medpace Holdings Price Quote

$337.01
-0.56 (0.56%)
(Updated: December 21, 2024 at 5:36 AM ET)

Medpace Holdings Key Stats

Sell
45
Medpace Holdings (MEDP) is a Sell
Day range:
$334.00 - $342.50
52-week range:
$277.72 - $459.77
Dividend yield:
0%
P/E ratio:
38.01
P/S ratio:
5.22
P/B ratio:
11.9%
Volume:
608.9K
Avg. volume:
333.4K
1-year change:
11.36%
Market cap:
$10.5B
Revenue:
$1.9B
EPS:
$11.42

How Much Does Medpace Holdings Make?

Data Unavailable

Is Medpace Holdings Growing As A Company?

Data Unavailable

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went up by 3.52% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 11.36% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Medpace Holdings?

Data Unavailable

Is Medpace Holdings Cash Flow Positive?

Data Unavailable

Medpace Holdings Return On Invested Capital

Data Unavailable

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • Fortrea Holdings Inc (FTRE)
    • IGC Pharma Inc (IGC)
    • IQVIA Holdings Inc (IQV)

Medpace Holdings Dividend Yield

Data Unavailable

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 35.59% 5.15%
Revenue: 8.29% -1.42%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 347.92
Upside from Last Price: 3.07%

Major Shareholders

Data Unavailable